The FDA’s anti-smoking campaign warning teens about “The Real Cost” of cigarettes was successful at preventing smoking initiation, according to the results of a nationwide survey. However, another study found that levels of e-cigarette use have increased among adolescents unlikely to start smoking cigarettes.
The FDA’s anti-smoking campaign warning teens about “The Real Cost” of cigarettes was successful at preventing smoking initiation, according to the results of a nationwide survey. However, another study found that levels of e-cigarette use have increased among adolescents unlikely to start smoking cigarettes.
The “Real Cost” campaign, which was the first federally funded tobacco education campaign when it began in 2014, aimed to prevent youth from trying cigarettes by reinforcing the central theme “Every cigarette costs you something.” The messages, which appeared on television, online, and in magazines, illustrated the loss of control due to nicotine addiction, the detrimental effects of smoking on one’s appearance, and the harmful mix of toxic chemicals present in cigarette smoke.
According to the results of a cohort study of US teenagers, the campaign achieved significant success in preventing smoking initiation. Of the 5185 respondents aged 11 to 16 who had never smoked at the beginning of the surveys, high exposure to the campaign was associated with a 30% decrease in the risk of starting to smoke. Additional analysis determined that an estimated 348,498 adolescents were potentially prevented from initiating smoking during the 2-year campaign period.
The study authors attributed the campaign’s success to the evidence-based development of its messaging and the high saturation across multiple channels of media aimed at this age group.
“These results demonstrate the effectiveness of a national campaign that focused on the harmful effects of smoking and delivered salient messages that resonated with youths,” they wrote. “Sustained tobacco education campaigns such as ‘The Real Cost’ can encourage US youths to abstain from tobacco use and accelerate progress toward future tobacco-free generations.”
However, not all recent research on teen nicotine use has been so encouraging. A new study published in Pediatrics indicated that e-cigarette use is not responsible for the decline in smoking rates among adolescents, as had been previously suggested. In fact, the researchers found that e-cigarettes are attracting young people who were at low risk of beginning to smoke traditional cigarettes.
The study analyzed several psychosocial characteristics common among smokers, like living with a smoker or wearing clothing with tobacco company logos. The cigarette smokers among the 140,000 middle and high school students surveyed between 2004 and 2014 generally displayed these characteristics, but those who just used e-cigarettes were less likely to report these qualities. A predictive model using these characteristics identified less than 25% of the e-cigarette users as likely to be current smokers.
“The introduction of e-cigarettes was not associated with a change in the linear decline in cigarette smoking among youth,” the authors concluded. “E-cigarette—only users would be unlikely to have initiated tobacco product use with cigarettes.”
In May 2016, the FDA expanded its authority to cover all tobacco products, allowing it to ban the sale of e-cigarettes to anyone younger than 18 and require manufacturers to include a nicotine warning on the packaging. However, concerns persisted about the prevalence of e-cigarette advertising that targeted teenagers.
A report on youth e-cigarette use issued by the Surgeon General in December 2016 accused e-cigarette marketing of “promoting flavors and using a wide variety of media channels and approaches” similar to those that had previously been used to attract young people to conventional cigarettes. It suggested steps like “regulation of e-cigarette marketing likely to attract youth, and educational initiatives targeting youth and young adults.”
In the report’s preface, CDC Director Thomas R. Frieden, MD, MPH, cited the FDA’s “Real Cost” campaign as an example of a “hard-hitting media campaign” that could be adapted to prevent young people from trying e-cigarettes or moving from experimentation to regular use.
Eye Changes After Cataract Surgery Associated With Diabetic Retinopathy
December 11th 2023Patients receiving uncomplicated phacoemulsification surgery for cataracts had greater increases in macular and choroidal thickness if they had early diabetic retinopathy without preoperative diabetic macular edema.
Read More
Results Show Strong Responses for Brentuximab Vedotin Plus Nivolumab Combo in Patients With cHL
December 11th 2023Use of an antibody drug conjugate and a PD-1 inhibitor brings complementary mechanisms together while eliminating the most toxic agent that has been used in combinations to treat classic Hodgkin lymphoma (cHL).
Read More
ICYMI: Highlights From the ACCC Fall National Oncology Conference
December 11th 2023This year’s top content from the fall meeting of the Association of Community Cancer Centers (ACCC) highlights both treatment gains made through innovative referral, screening, and assistance initiatives and the ongoing need to improve health equity and research inclusivity.
Read More